TERMINATION OF LEASETermination of Lease • February 28th, 2018 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2018 Company Industry JurisdictionTHIS TERMINATION OF LEASE (this “Agreement”) is made as of the 31st day of December, 2017, by and between ONE HUDSON YARDS OWNER LLC, a Delaware limited liability company (“Landlord”), having an office at c/o Related Companies, 60 Columbus Circle, New York, New York 10023, and INTERCEPT PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”), having an office at 10 Hudson Yards, 37th Floor, New York, NY 10001.
AMENDMENT #1 TO MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • February 28th, 2018 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2018 Company IndustryTHIS AMENDMENT #1 TO MANUFACTURING AND SUPPLY AGREEMENT (this “Amendment #1”) dated the 12th day of December, 2017 (the “Amendment #1 Effective Date”) is made by and between Intercept Pharma Europe Ltd., having a location at 2 Pancras Square, Floor 1, London, United Kingdom N1C 4AG (“Intercept”), and PharmaZell GmbH, a corporation organized under the laws of Germany (“PharmaZell”). Intercept and PharmaZell are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
SEPARATION AGREEMENTSeparation Agreement • February 28th, 2018 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2018 Company Industry JurisdictionThis Separation Agreement (the “Agreement”) is between Rachel McMinn (“Employee”), on behalf of Employee and all of Employee’s heirs, executors, administrators and successors (individually and collectively, “Releasors”) and Intercept Pharmaceuticals, Inc. (the “Company”), on behalf of the Company and all of its past, present, and future parents, subsidiaries, divisions, affiliates, directors, officers, managers, members, agents, successors, assigns, former employees and employees (individually and collectively, the “Company Parties”) for the purpose of the termination of Employee’s employment relationship with the Company effective December 31, 2017 (the “Termination Date”) and detailing their respective rights and obligations.